Biotech Business 43 Views Genmab’s BLA accepted for priority review Malin Otmani April 13, 2021 Genmab and Seagen have announced …
Clinical Trials 460 Views Genmab and Seattle Genetics present new data Malin Otmani September 22, 2020 Genmab and Seattle Genetics has …
Agreement 705 Views Genmab enters into agreement with Tempus Malin Otmani October 3, 2019 Genmab has entered into a …
New Market 1646 Views Approval for Genmab’s DARZALEX in Japan Malin Otmani October 2, 2017 The Ministry of Health, Labor …
Agreement 1068 Views Genmab and Seattle Genetics in co-development agreement Malin Otmani August 30, 2017 Genmab and Seattle Genetics announces …
Pharma Business 1098 Views Genmab announces European marketing authorization for DARZALEX Malin Otmani May 3, 2017 Genmab announces that the European …
Clinical Trials 1115 Views Genmab announces new phase III study Malin Otmani May 2, 2017 Genmab announces that Janssen Research …
In a new job 1627 Views Genmab appoints new Chief Development Officer Malin Otmani February 9, 2017 Genmab has appointed Judith Klimovsky, MD, …
Pharma Business 1142 Views Genmab receives USD 25 million in sales milestone Malin Otmani January 9, 2017 Genmab A/S has achieved the …
Pharma Business 1193 Views FDA approval for Genmab Malin Otmani November 22, 2016 The U.S. Food and Drug …
Clinical Trials 1059 Views Genmab announces Phase III Study Malin Otmani November 3, 2016 Genmab announces that daratumumab (DARZALEX) …
Drug Development Pharma 1030 Views Genmab announces European Regulatory Submission Malin Otmani August 24, 2016 Genmab announced yesterday that Janssen …
Drug Development Pharma 1099 Views Genmab submits FDA application for Daratumumab Malin Otmani August 18, 2016 Genmab has announced that its licensing …
Agreement 1254 Views Genmab in new agreement Malin Otmani August 15, 2016 Genmab has entered an agreement …
Clinical Trials 1054 Views Genmab anounce Phase III studies Malin Otmani June 2, 2016 Genmab A/S announces that its …
Pharma Business 1086 Views Genmab’s Darzalex receives market authorization Malin Otmani May 25, 2016 Genmab A/S announces that the …